1. Home
  2. ASAN vs ABCL Comparison

ASAN vs ABCL Comparison

Compare ASAN & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Asana Inc.

ASAN

Asana Inc.

HOLD

Current Price

$6.84

Market Cap

1.6B

Sector

Technology

ML Signal

HOLD

Logo AbCellera Biologics Inc.

ABCL

AbCellera Biologics Inc.

HOLD

Current Price

$5.75

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ASAN
ABCL
Founded
2008
2012
Country
United States
Canada
Employees
N/A
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.6B
IPO Year
2020
2020

Fundamental Metrics

Financial Performance
Metric
ASAN
ABCL
Price
$6.84
$5.75
Analyst Decision
Hold
Strong Buy
Analyst Count
14
5
Target Price
$12.46
$8.40
AVG Volume (30 Days)
5.5M
7.5M
Earning Date
06-02-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
27.93
10.91
EPS
N/A
N/A
Revenue
$790,806,000.00
$75,128,000.00
Revenue This Year
$10.19
N/A
Revenue Next Year
$7.91
$21.85
P/E Ratio
N/A
N/A
Revenue Growth
9.25
160.56
52 Week Low
$5.38
$2.75
52 Week High
$15.71
$8.44

Technical Indicators

Market Signals
Indicator
ASAN
ABCL
Relative Strength Index (RSI) 42.19 42.26
Support Level $6.45 $5.23
Resistance Level $6.88 $6.79
Average True Range (ATR) 0.50 0.59
MACD -0.03 -0.24
Stochastic Oscillator 15.89 7.07

Price Performance

Historical Comparison
ASAN
ABCL

About ASAN Asana Inc.

Asana Inc is the system of action for work, built for the Agentic Enterprise. It provides a comprehensive solution where humans and AI agents can collaborate effectively so that individuals work smarter, teams move faster, and organizations deliver results. Companies use Asana to connect their work to company goals and orchestrate mission-critical workflows like product launches, employee onboarding, resource planning, tracking company-wide strategic initiatives and more. It manages its operations and allocates resources as a single operating and reportable segment. The company generates revenues from subscriptions from paying customers accessing its cloud-based platform.

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is a clinical-stage biotechnology company focused on discovering and developing first-in-class antibody medicines for indications with high unmet medical need. It has built a platform for advancing antibody drug programs that the company believes provides it with a competitive advantage in addressing challenging, high-value targets such as complex transmembrane proteins and novel modalities, including multispecifics and antibody-drug conjugates. Organisation's pipeline includes two drug candidates in clinical development, two development candidates in Investigational New Drug (IND/Clinical Trial Application (CTA)-enabling activities, and more than 20 active discovery programs across multiple modalities and indications.

Share on Social Networks: